Literature DB >> 11553601

Purification of anthrax edema factor from Escherichia coli and identification of residues required for binding to anthrax protective antigen.

P Kumar1, N Ahuja, R Bhatnagar.   

Abstract

The structural gene for anthrax edema factor (EF) was expressed in Escherichia coli under the control of a powerful T5 promoter to yield the 89-kDa recombinant protein that reacted with anti-EF antibodies. Recombinant EF was purified to homogeneity by a two-step procedure involving metal chelate affinity chromatography and cation-exchange chromatography. From 1 liter of culture, 2.5 mg of biologically active EF was easily purified. This is the first report of purification of anthrax EF from E. coli. EF purified from E. coli was biologically and functionally as active as its Bacillus anthracis counterpart. The recombinant protein could compete with lethal factor for binding to protective antigen. Sequence analysis revealed a stretch of seven amino acids, Val Tyr Tyr Glu Ile Gly Lys, present both in EF (residues 136 to 142) and lethal factor (residues 147 to 153). To investigate the role of these seven residues in binding to protective antigen, the residues were individually mutated to alanine in EF. Mutations in residues Tyr137, Tyr138, Ile140, and Lys142 of EF specifically blocked its interaction with anthrax protective antigen. The adenylate cyclase activity of the mutants remained unaffected. The results suggested that residues Tyr137, Tyr138, Ile140, and Lys142 are required for binding of EF to anthrax protective antigen, which facilitates its entry into susceptible cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553601      PMCID: PMC98792          DOI: 10.1128/IAI.69.10.6532-6536.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Purification of factor I and recognition of a third factor of the anthrax toxin.

Authors:  J L STANLEY; H SMITH
Journal:  J Gen Microbiol       Date:  1961-09

2.  Purification and characterization of adenylyl cyclase from Bacillus anthracis.

Authors:  S H Leppla
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

3.  Structural homology between virulence-associated bacterial adenylate cyclases.

Authors:  V Escuyer; E Duflot; O Sezer; A Danchin; M Mock
Journal:  Gene       Date:  1988-11-30       Impact factor: 3.688

4.  Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis.

Authors:  P Gupta; A Singh; V Chauhan; R Bhatnagar
Journal:  Biochem Biophys Res Commun       Date:  2001-01-12       Impact factor: 3.575

5.  Expression and purification of the recombinant protective antigen of Bacillus anthracis.

Authors:  P Gupta; S M Waheed; R Bhatnagar
Journal:  Protein Expr Purif       Date:  1999-08       Impact factor: 1.650

6.  Anthrax protective antigen forms oligomers during intoxication of mammalian cells.

Authors:  J C Milne; D Furlong; P C Hanna; J S Wall; R J Collier
Journal:  J Biol Chem       Date:  1994-08-12       Impact factor: 5.157

7.  Characterization of macrophage sensitivity and resistance to anthrax lethal toxin.

Authors:  A M Friedlander; R Bhatnagar; S H Leppla; L Johnson; Y Singh
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

8.  Calcium is required for the expression of anthrax lethal toxin activity in the macrophagelike cell line J774A.1.

Authors:  R Bhatnagar; Y Singh; S H Leppla; A M Friedlander
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

9.  Nucleotide sequence of the Bacillus anthracis edema factor gene (cya): a calmodulin-dependent adenylate cyclase.

Authors:  D L Robertson; M T Tippetts; S H Leppla
Journal:  Gene       Date:  1988-12-20       Impact factor: 3.688

10.  Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process.

Authors:  A M Friedlander
Journal:  J Biol Chem       Date:  1986-06-05       Impact factor: 5.157

View more
  9 in total

1.  Residue histidine 669 is essential for the catalytic activity of Bacillus anthracis lethal factor.

Authors:  Sha Cao; Aizhen Guo; Gaobing Wu; Ziduo Liu; Wei Chen; Chunfang Feng; Cheng-Cai Zhang; Huanchun Chen
Journal:  J Bacteriol       Date:  2010-09-10       Impact factor: 3.490

2.  A chimeric protein that functions as both an anthrax dual-target antitoxin and a trivalent vaccine.

Authors:  Gaobing Wu; Yuzhi Hong; Aizhen Guo; Chunfang Feng; Sha Cao; Cheng-Cai Zhang; Ruiping Shi; Yadi Tan; Ziduo Liu
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

Review 3.  Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy.

Authors:  Kevin Sherer; Yan Li; Xizhong Cui; Peter Q Eichacker
Journal:  Am J Respir Crit Care Med       Date:  2006-11-09       Impact factor: 21.405

4.  Molecular and Genomic Characterization of PFAB2: A Non-virulent Bacillus anthracis Strain Isolated from an Indian Hot Spring.

Authors:  Aparna Banerjee; Vikas K Somani; Priyanka Chakraborty; Rakesh Bhatnagar; Rajeev K Varshney; Alex Echeverría-Vega; Sara Cuadros-Orellana; Rajib Bandopadhyay
Journal:  Curr Genomics       Date:  2019-11       Impact factor: 2.236

Review 5.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

6.  Bacillus anthracis edema toxin impairs neutrophil actin-based motility.

Authors:  Sarah E Szarowicz; Russell L During; Wei Li; Conrad P Quinn; Wei-Jen Tang; Frederick S Southwick
Journal:  Infect Immun       Date:  2009-04-06       Impact factor: 3.441

7.  Anthrax edema toxin requires influx of calcium for inducing cyclic AMP toxicity in target cells.

Authors:  Praveen Kumar; Nidhi Ahuja; Rakesh Bhatnagar
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

8.  The major neutralizing antibody responses to recombinant anthrax lethal and edema factors are directed to non-cross-reactive epitopes.

Authors:  Melissa L Nguyen; Simon Terzyan; Jimmy D Ballard; Judith A James; A Darise Farris
Journal:  Infect Immun       Date:  2009-08-31       Impact factor: 3.441

Review 9.  Antibodies against anthrax: mechanisms of action and clinical applications.

Authors:  Jeffrey W Froude; Philippe Thullier; Thibaut Pelat
Journal:  Toxins (Basel)       Date:  2011-11-16       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.